Guggenheim Equal Weight Enhanced Equity Income Fund January

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Guggenheim Equal Weight Enhanced Equity Income Fund January 2014 Distribution

NEW YORK, Jan. 27, 2014 (GLOBE NEWSWIRE) -- Guggenheim Equal Weight Enhanced Equity Income Fund (NYSE: GEQ ) announced today important information concerning its distribution declared on January 2, 2014. This press release is issued as required by the Fund's managed distribution plan and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of a distribution policy to make quarterly cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the January 2014 distribution. It is not determinative of the tax character of the Fund's distributions for the calendar year. Shareholders should note that the Fund's total regular distribution amount is subject to change as a result of market conditions or other factors.

The amounts and sources of distributions reported in this notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

Distribution Period: January 2014
Record Date: January 15, 2014
Payable Date: January 31, 2014
Distribution Amount Per Common Share: $0.4375

The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date from the following sources: net investment income; net realized short-term capital gains; net realized long-term capital gains and return of capital. All amounts are expressed per common share.

         
  Current Distribution ($) % Breakdown of the Current Quarterly Distribution Total Cumulative Distributions for the Fiscal Year to Date ($) % Breakdown of the Total Cumulative Distributions for the Fiscal Year to Date
Net Investment Income $ 0.0116 2.65% $ 0.0116 2.65%
Net Realized Short- Term Capital Gains -- -- -- --
Net Realized Long- Term Capital Gains -- -- -- --
Return of Capital $ 0.4259 97.35% $ 0.4259 97.35%
Total (per common share) $ 0.4375 100.00% $ 0.4375 100.00%

You should not necessarily draw any conclusions about the Fund's investment performance from the amount of this distribution or from the terms of the Fund's managed distribution plan.

The Fund estimates that it has distributed more than its income and capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund's Investment performance and should not be confused with "yield" or "income".

Set forth in the table below is information relating to the Fund's performance based on its net asset value (NAV) for certain periods.

   
Average annual total return (in relation to NAV) for the period since inception (October 27, 2011) to December 31, 2013 13.33%
Annualized current distribution rate expressed as a percentage of NAV as of December 31, 2013 8.33%
Cumulative total return (in relation to NAV) for the fiscal year through December 31, 2013 20.28%
Annualized cumulative fiscal year distributions as a percentage of NAV as of December 31, 2013 8.33%

About Guggenheim Investments

Guggenheim Investments represents the investment management division of Guggenheim Partners, LLC ("Guggenheim"), which consists of investment managers with approximately $172 billion in combined total assets*. Collectively, Guggenheim Investments has a long, distinguished history of serving institutional investors, ultra-high-net-worth individuals, family offices and financial intermediaries. Guggenheim Investments offers clients a wide range of differentiated capabilities built on a proven commitment to investment excellence. Guggenheim Investments has offices in Chicago, New York City and Santa Monica, along with a global network of offices throughout the United States, Europe, and Asia.

Guggenheim Investments is comprised of several investment management entities within Guggenheim, which includes Guggenheim Funds Distributors, LLC and Guggenheim Funds Investment Advisors, LLC (together, "Guggenheim Funds") . Guggenheim Funds Investment Advisors, LLC serves as Investment Adviser for GEQ .

* Guggenheim Investments total asset figure is as of 12.31.2013 and includes $12.497B of leverage for Assets Under Management and $0.390B of leverage for Serviced Assets.  Total assets include assets from Security Investors, LLC, Guggenheim Partners Investment Management, LLC, Guggenheim Funds and its affiliated entities, and some business units including Guggenheim Real Estate, LLC, Guggenheim Aviation, GS GAMMA Advisors, LLC, Guggenheim Partners Europe Limited, Transparent Value Advisors, LLC, and Guggenheim Partners India Management.  Values from some funds are based upon prior periods.

This information does not represent an offer to sell securities of the Fund and it is not soliciting an offer to buy securities of the Fund. There can be no assurance that the Fund will achieve its investment objective. Investments in the Fund involve operating expenses and fees. The net asset value of the Fund will fluctuate with the value of the underlying securities. It is important to note that closed-end funds trade on their market value, not net asset value, and closed-end funds often trade at a discount to their net asset value. Past performance is not indicative of future performance. An investment in closed-end funds is subject to investment risk, including the possible loss of the entire amount that you invest. Some general risks and considerations associated with investing in a closed-end fund include: Investment and Market Risk; Lower Grade Securities Risk; Equity Securities Risk; Foreign Securities Risk; Interest Rate Risk; Illiquidity Risk; Derivative Risk; Management Risk; Anti-Takeover Provisions; Market Disruption Risk and Leverage Risk. See www.guggenheiminvestments.com/cef for a detailed discussion of fund-specific risks.

Investors should consider the investment objectives and policies, risk considerations, charges and expenses of any investment before they invest. For this and more information visit www.guggenheiminvestments.com   or contact a securities representative or Guggenheim Funds Distributors, LLC 2455 Corporate West Drive, Lisle, IL 60532, 800-345-7999.

NOT FDIC-INSURED | NOT BANK-GUARANTEED | MAY LOSE VALUE
Member FINRA/SIPC (1/14)

Analyst Inquiries William T. Korver 630.505.3700 Media Inquiries Jeaneen Pisarra 212.518.5367

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Altea Targets US Market, Appoints Rodrick VP Amid Expansion

Updated Category News Views 58

Wading into the murky waters of U.S. healthcare insurance isn't for the faint of heart, but Altea's making its move. Backed by MISSION, they're banking on a niche strategy by tapping veteran Justin Rodrick as Vice President. Their tactic? Aim squarely at the under-served segment of small to mid-sized medical and healthcare facilities. The play's bold, and if Rodrick's got...

Continue Reading
Navigating Home Care: What Families Need to Know

Updated Category News Views 94

Peeking into the Home Care Playbook The process of starting home care isn't some mind-boggling puzzle. For families in Northeastern Pennsylvania, things kick off with a cordial chinwag with a care coordinator—no paperwork chains or Kafkaesque contracts right off the bat. Now, if you've got someone in need of care, this gives you time to shove all your questions onto the...

Continue Reading
Innovative Trial Targets Drug Resistance in Lung Cancer

Updated Category News Views 0

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Continue Reading
Kimberly-Clark Extends Kenvue Notes Exchange Deadline

Updated Category News Views 72

Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...

Continue Reading
Epilepsy Market's Explosive Growth Forecasted to 2036

Updated Category News Views 113

It's a wild world out there for epilepsy treatments—like a relentless bull run with everyone eyeing the prize. The latest buzz points to a fat 2036 forecast for this sector, driven by a mix of standout technologies and breakthrough therapies. You'd be a fool to blink and miss it. Rising Numbers Stir the Market The numbers, oh boy, they're climbing. In 2025, about 7...

Continue Reading
Don Silvestri: NFL Vet's Service Legacy Continues

Updated Category News Views 64

More Than Just a Debt Guru It's not every day you see a former NFL player shifting gears so smoothly into the corporate world, and then to community service like a missile lock. But that's exactly what Don Silvestri, president of Debt.com, has done. Dragging a hefty reputation as a placekicker for teams like the New York Jets and the Buffalo Bills, he's now making...

Continue Reading
CORE Embraces Tech to Boost Organ Donation Efforts

Updated Category News Views 73

Innovation Meets Organ Donation Out of all the business moves you hear about, this one rings loud because it doesn’t just move the needle on a spreadsheet—it moves the needle on life or death. The Center for Organ Recovery & Education (CORE) is stepping into the future with a high-tech touch to enhance their lifesaving mission. Partnering with InVita Healthcare...

Continue Reading
MillerKnoll's 3D Push: Legacy Meets Innovation

Updated Category News Views 42

Bringing the Classics to the Digital Frontier Here's what's lighting a fire under the world of high-end furniture: MillerKnoll's got its eye on the prize by jazzing up Knoll.com with shiny new 3D product configurators. It's like taking a century's worth of design stuffiness and spinning it into the future, ready to dazzle a whole new set of eyeballs. Why This Move Matters...

Continue Reading
Dotwork's AI Leap: Acquires Arcario to Revolutionize Strategy

Updated Category News Views 84

Transformations in enterprise management are knocking at the door with Dotwork's latest move. Their strategic acquisition of Arcario Group aims to flip the lid on how companies tie strategies to their daily grind using AI. Let me level with you—this ain't about just spicing up some dashboards or workflows. We're talking about an enterprise-level overhaul in the very way...

Continue Reading
Boeing's Third Quarter 2026: Progress Amid Losses

Updated Category News Views 97

Boeing's Rocky Rollercoaster Ride This Quarter Man, if you want a case study on turbulence in the business world, look no further than Boeing's recent third-quarter performance. This juggernaut managed to clock in $24.2 billion in revenues, up 4% from last year, but it still can't seem to shake off its streak of red ink. We're talking a net loss of $116 million, or a GAAP...

Continue Reading

Top 5 Most Recently Viewed Articles

Bitget Shines as Key Partner of the Crypto Jazz Festival

Updated Category News Views 194

Bitget Joins the Crypto Jazz Festival in Montreux Bitget, a prominent name in the cryptocurrency exchange and Web3 space, is delighted to announce its collaboration as a primary partner for the inaugural Crypto Jazz Festival. Set against the backdrop of the renowned Montreux Jazz Festival, this innovative event is designed to incorporate the world of cryptocurrency with...

Continue Reading
Compass Diversified Reveals Q3 2024 Earnings Call Details

Updated Category News Views 57

Compass Diversified Sets Date for Q3 2024 Earnings Release Compass Diversified (NYSE: CODI), located in Westport, Connecticut, has officially announced its plans to unveil the financial results for the third quarter that concluded on September 30, 2024. This announcement is scheduled for a release on Wednesday, October 30, 2024, just after market trading concludes. The...

Continue Reading
US Dollar's Mixed Performance Amidst Economic Data Releases

Updated Category News Views 100

US Data to Influence Fed Rate Cut Expectations The US dollar shows a complex performance against its major peers, particularly facing challenges only against the Australian dollar. Recently, the Australian dollar has reached levels not seen in 15 months, showcasing a strong upward trajectory. Despite the ups and downs, market analysts suggest that the dollar’s movements...

Continue Reading
Rémy Martin Celebrates Lunar New Year with Artistic Brilliance

Updated Category News Views 155

Rémy Martin Celebrates Lunar New Year with Art The renowned House of Rémy Martin proudly announces a remarkable collaboration with celebrated Chinese artist Xue Song to honor the Lunar New Year. This year's theme, inspired by the Year of the Horse, sees Xue Song reinterpreting the iconic Centaur figure associated with Rémy Martin, translating its symbolism into a...

Continue Reading
Trulieve Cannabis Corp. Unveils Upcoming Event Plans

Updated Category News Views 116

Exciting Upcoming Events for Trulieve Cannabis Corp Trulieve Cannabis Corp (CSE: TRUL, OTCQX: TCNNF) is making waves in the cannabis sector with its recent announcement regarding its participation in various significant events coming up in the near future. Known for being a leading company in the cannabis market, Trulieve continues to solidify its reputation through...

Continue Reading